Endoscopic diagnosis and evaluation of the effectiveness of combination chemotherapy of small cell lung cancer
Poddubnyĭ, B.K.
Voprosy Onkologii 31(10): 18-21
1985
ISSN/ISBN: 0507-3758 PMID: 2998081 Document Number: 242235
The results of bronchoscopy for small cell lung carcinoma demonstrated endoscopic procedure to provide much reliable information indispensable in making primary diagnosis and evaluating the efficacy of combined chemotherapy. It was shown that assessment of the results of chemotherapy for lung cancer should be carried out on the basis of a wide range of parameters (including endoscopic and roentgenologic findings) as determined by the resolution of relevant diagnostic procedures for different types of tumor growth.
Document emailed within 1 workday
Related Documents
Maneechawakajorn, J.; Suksuperm, J. 2014: Quality of life in advanced non-small cell lung cancer receiving chemotherapy of platinum combination in old versus new standard chemotherapy regimen Journal of the Medical Association of Thailand 97(Suppl 11): S69-S75Masuda, N. 1997: Combination chemotherapy in the treatment of inoperable non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(Suppl 3): 379-383
Lai, S.L.; Perng, R.P. 2000: Combination versus alternating chemotherapy in small-cell lung cancer Zhonghua Yi Xue Za Zhi 63(7): 513-520
Wolf, H.; Jassem, E.; Cynowska, B.ła.; Damps, I.; Mierzejewska, E.; Słomiński, J.M. 2002: Chemotherapy of advanced non-small cell lung cancer with the combination of gemcitabine and cisplatin Pneumonologia i Alergologia Polska 70(1-2): 44-51
Ito, Y.; Ogawa, M.; Horikoshi, N.; Inoue, K.; Mukaiyama, T.; Imajou, K.; Ozeki, H.; Nagamine, D.; Shinagawa, K. 1987: Combination chemotherapy with cis-platinum, vinblastine and adriamycin for non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(12): 3295-3300
Joss, R.A.; Alberto, P.; Obrecht, J.P.; Barrelet, L.; Holdener, E.E.; Siegenthaler, P.; Goldhirsch, A.; Mermillod, B.; Cavalli, F. 1984: Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide Cancer Treatment Reports 68(9): 1079-1084
Seike, M.; Andoh, M.; Hasegawa, K.; Sakonji, M.; Tsuboi, E. 1998: Combination chemotherapy with continuous infusion of low-dose cisplatin and UFT for advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(10): 1539-1542
Oyamada, Y.; Watanabe, H.; Fukunaga, K.; Nakamura, H.; Asano, K.; Hasegawa, N.; Yamaguchi, K. 2003: Effects of docetaxel dosage in combination chemotherapy with carboplatin against advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(12): 1917-1922
Hoffman, P.C.; Masters, G.A.; Drinkard, L.C.; Krauss, S.A.; Samuels, B.L.; Golomb, H.M.; Vokes, E.E. 1996: Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies Seminars in Oncology 23(3 Suppl 6: 11-15
Fram, R.; Skarin, A.; Balikian, J.; Amato, D.; Leslie, N.; Malcolm, A.; Frei, E. 1985: Combination chemotherapy followed by radiation therapy in patients with regional stage IIi unresectable non-small cell lung cancer Cancer Treatment Reports 69(6): 587-590
Chen, Y.M.; Perng, R.P.; Yang, K.Y.; Wu, H.W.; Lin, W.C.; Liu, J.M.; Tsai, C.M.; Whang-Peng, J. 2000: Combination chemotherapy with tamoxifen, ifosfamide, epirubicin and cisplatin in extensive-disease small-cell lung cancer Zhonghua Yi Xue Za Zhi 63(8): 605-611
Kaira, K.; Ishizuka, T.; Yanagitani, N.; Sunaga, N.; Hisada, T.; Mori, M. 2007: Effective combination chemotherapy of carboplatin and paclitaxel in the treatment of a recurrent small-cell lung cancer patient Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(2): 225-227
Yoshida, T.; Mori, K.; Kamiyama, Y.; Tominaga, K. 2001: Effective combination chemotherapy using paclitaxel in the treatment of a small-cell lung cancer patient resistant to multiple drugs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(10): 1437-1440
Palmer, A.J.; Brandt, A. 1996: The cost-effectiveness of four cisplatin-containing chemotherapy regimens in the treatment of stages IIi B and IV non-small cell lung cancer: an Italian perspective Monaldi Archives for Chest Disease 51(4): 279-288
Tanaka, A.; Aragane, N.; Komiya, K.; Kawaura, F.; Fukuno, Y.; Hayashi, S. 2008: A pilot study of irinotecan hydrochloride(CPT-11)and cisplatin(CDDP)combination chemotherapy for previously treated non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(1): 49-53
Sato, N.; Nakamura, Y.; Kishimoto, K.; Ebina, A.; Imai, T. 2010: A phase Ii study of gemcitabine and carboplatin bi-weekly combination chemotherapy for complete resected non-small-cell lung cancer patients Kyobu Geka. Japanese Journal of Thoracic Surgery 63(10): 849-852
Mito, A.; Yamasaki, M.; Ohashi, N.; Kajihara, T.; Nitta, T.; Awaya, H.; Ikegami, Y.; Arita, K-ichi. 2010: A retrospective study of carboplatin and weekly paclitaxel combination chemotherapy for elderly patients with advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(9): 1707-1711
Sakuma, F.; Kuroda, M.; Takagi, T.; Terashima, K.; Ohishi, A.; Noguchi, S.; Mizuno, A. 1999: Evaluation of chemotherapy with docetaxel and cisplatin in advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(7): 927-932
Crvenkova, S.; Pesevska, M. 2015: Important prognostic factors for the long-term survival in non-small cell lung cancer patients treated with combination of chemotherapy and conformal radiotherapy Journal of Buon: Official Journal of the Balkan Union of Oncology 20(3): 775-781
Evans, W.K. 1988: Combination chemotherapy confers modest survival advantage in patients with advanced non-small cell lung cancer: report of a Canadian multicenter randomized trial Seminars in Oncology 15(6 Suppl. 7): 42-45